Skip to main navigation Skip to search Skip to main content

A Two-year Observational Study to Evaluate the Safety Profile of Fingolimod in Patients with Multiple Sclerosis who Switch from Natalizumab to Fingolimod

Project: Research

Project Details

StatusFinished
Effective start/end date11/13/13 → 07/21/16

Funding

  • Novartis Pharmaceuticals Corporation: $3,000.00